toleration
Showing 1 - 2 of 2
Phase 1, Multiple Dose, Safety Trial in Bruxelles (UK-396,082, )
Completed
- Phase 1
- +4 more
- UK-396,082
- placebo
-
Bruxelles, BelgiumPfizer Investigational Site
Nov 30, 2018
Phase 1, Single Dose, Safety Trial in Bruxelles (PF-05212372, Placebo)
Completed
- Phase 1
- +4 more
- PF-05212372
- Placebo
-
Bruxelles, BelgiumPfizer Investigational Site
Aug 12, 2011